Upadacitinib Versus IL-17 Inhibitors in Patients With Psoriatic Arthritis

Clinical trial NCT07386717 · COMPLETED

Trial details

NCT number: NCT07386717
Sponsor: Peking University First Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Psoriatic Arthritis Upadacitinib Interleukin-17 Inhibitors

Start date: 2024-01-01
Primary completion: 2025-12-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.